Title | Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Yang, D, Jones, MG, Naranjo, S, Rideout, WM, Min, KHoi Joseph, Ho, R, Wu, W, Replogle, JM, Page, JL, Quinn, JJ, Horns, F, Qiu, X, Chen, MZ, Freed-Pastor, WA, McGinnis, CS, Patterson, DM, Gartner, ZJ, Chow, ED, Bivona, TG, Chan, MM, Yosef, N, Jacks, T, Weissman, JS |
Journal | Cell |
Volume | 185 |
Issue | 11 |
Pagination | 1905-1923.e25 |
Date Published | 2022 May 26 |
ISSN | 1097-4172 |
Keywords | Animals, Exome Sequencing, Genes, ras, Mice, Neoplasms, Phylogeny |
Abstract | <p>Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that enable uncontrolled growth and expansion to neighboring and distal tissues. The study of phylogenetic relationships between cancer cells provides key insights into these processes. Here, we introduced an evolving lineage-tracing system with a single-cell RNA-seq readout into a mouse model of Kras;Trp53(KP)-driven lung adenocarcinoma and tracked tumor evolution from single-transformed cells to metastatic tumors at unprecedented resolution. We found that the loss of the initial, stable alveolar-type2-like state was accompanied by a transient increase in plasticity. This was followed by the adoption of distinct transcriptional programs that enable rapid expansion and, ultimately, clonal sweep of stable subclones capable of metastasizing. Finally, tumors develop through stereotypical evolutionary trajectories, and perturbing additional tumor suppressors accelerates progression by creating novel trajectories. Our study elucidates the hierarchical nature of tumor evolution and, more broadly, enables in-depth studies of tumor progression.</p> |
DOI | 10.1016/j.cell.2022.04.015 |
Alternate Journal | Cell |
PubMed ID | 35523183 |
PubMed Central ID | PMC9452598 |
Grant List | T32 GM007287 / GM / NIGMS NIH HHS / United States U01 CA217882 / CA / NCI NIH HHS / United States P30 CA014051 / CA / NCI NIH HHS / United States T32 GM007753 / GM / NIGMS NIH HHS / United States F31 CA257349 / CA / NCI NIH HHS / United States F32 GM125247 / GM / NIGMS NIH HHS / United States R01 CA204302 / CA / NCI NIH HHS / United States F31 NS115380 / NS / NINDS NIH HHS / United States U54 CA224081 / CA / NCI NIH HHS / United States RM1 HG009490 / HG / NHGRI NIH HHS / United States / HHMI / Howard Hughes Medical Institute / United States R01 CA211052 / CA / NCI NIH HHS / United States R01 CA231300 / CA / NCI NIH HHS / United States R01 CA169338 / CA / NCI NIH HHS / United States F32 GM128366 / GM / NIGMS NIH HHS / United States |